Huabao International Holdings Limited (0336.HK)
Hong Kong, HK
Huabao International Holdings Limited, an investment holding company, engages in the research and development, production, distribution, and sale of flavors, fragrances, food ingredients, tobacco and aroma raw materials, and condiments primarily in the People's Republic of China. It offers paper-making products, reconstituted tobacco leaves, and new material products for the tobacco industry. The company is also involved in the production and sale of natural extracts; tobacco flavours and fragrances; cigarette paper and auxiliary products; synthetic perfumes; and food flavors and fragrances, as well as offers administrative and management and consultancy services. Huabao International Holdings Limited was incorporated in 1991 and is headquartered in Wan Chai, Hong Kong.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.28% | -0.83% | -19.91% | -20.97% | -0.28% | -10.28% | +20.95% | +14.74% | -71.45% | +19.33% | +1,888.89% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+3.3% Q4'25: +5.2% (vs Q4'23)
-
EPS growth Chemicals - Specialty: +13.2%+0.0% Q4'25: -747.8% (vs Q4'23)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+10.3% ★ Q4'25: +31.5% (vs Q4'23)
-
EBIT margin Chemicals - Specialty: +8.8%+2.0% Q4'25: -0.8% (vs Q4'23)
-
ROIC Chemicals - Specialty: +5.6%+1.0% Q4'25: -0.9% (vs Q4'23)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q4'25: +0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.47× ★ Q4'25: 0.30× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.69B
est: 3.15B (-14.6%)
|
2.92B
est: 3.76B (-22.3%)
|
3.39B
est: 3.64B (-6.8%)
|
3.46B
est: 2.87B (+20.6%)
|
3.28B
est: 2.94B (+11.6%)
|
3.48B
est: 3.81B (-8.6%)
|
3.85B
est: 4.11B (-6.4%)
|
4.08B
est: 4.11B (-0.8%)
|
4.24B
est: 5.33B (-20.4%)
|
3.85B
est: 4.23B (-8.8%)
|
3.88B
est: 4.34B (-10.6%)
|
3.83B
est: 4.16B (-8.1%)
|
3.31B
est: 4.58B (-27.8%)
|
3.37B
est: 5.05B (-33.2%)
|
4.64B
4.64B – 4.64B
-8.2% YoY
|
5.61B
5.61B – 5.61B
+21.0% YoY
|
6.43B
6.43B – 6.43B
+14.6% YoY
|
| EBITDA |
1.79B
est: 640.95M (+179.8%)
|
1.77B
est: 764.53M (+131.1%)
|
2.10B
est: 740.07M (+183.4%)
|
2.05B
est: 584.62M (+250.8%)
|
1.68B
est: 597.46M (+181.8%)
|
1.55B
est: 775.66M (+99.4%)
|
2.07B
est: 836.64M (+147.4%)
|
1.89B
est: 836.64M (+125.6%)
|
2.20B
est: 1.08B (+102.7%)
|
1.37B
est: 859.91M (+58.9%)
|
1.51B
est: 883.78M (+70.4%)
|
-352.00M
est: 847.49M (-141.5%)
|
758.37M
est: 932.15M (-18.6%)
|
464.38M
est: 778.55M (-40.4%)
|
715.09M
715.09M – 715.09M
-8.2% YoY
|
865.02M
865.02M – 865.02M
+21.0% YoY
|
991.40M
991.40M – 991.40M
+14.6% YoY
|
| EBIT |
1.70B
est: 384.81M (+342.8%)
|
1.65B
est: 459.00M (+260.6%)
|
1.94B
est: 444.32M (+337.3%)
|
1.92B
est: 350.99M (+447.4%)
|
1.50B
est: 358.70M (+319.2%)
|
1.41B
est: 465.68M (+203.6%)
|
1.86B
est: 502.30M (+270.9%)
|
1.69B
est: 502.30M (+236.9%)
|
1.93B
est: 650.87M (+197.3%)
|
1.09B
est: 516.26M (+111.7%)
|
1.23B
est: 530.59M (+131.6%)
|
-682.24M
est: 508.81M (-234.1%)
|
440.77M
est: 559.64M (-21.2%)
|
188.11M
est: 350.96M (-46.4%)
|
322.35M
322.35M – 322.35M
-8.2% YoY
|
389.94M
389.94M – 389.94M
+21.0% YoY
|
446.91M
446.91M – 446.91M
+14.6% YoY
|
| Net Income |
1.42B
|
1.37B
|
1.58B
est: 1.50B (+5.7%)
|
1.59B
est: 1.65B (-3.4%)
|
1.21B
est: 137.01M (+782.6%)
|
1.07B
est: 1.19B (-10.6%)
|
1.26B
est: 1.34B (-5.9%)
|
1.17B
est: 1.34B (-12.6%)
|
1.11B
est: 1.57B (-29.1%)
|
418.40M
est: 1.16B (-63.9%)
|
675.13M
est: 1.10B (-38.7%)
|
-1.05B
est: 613.52M (-271.9%)
|
233.63M
est: 734.03M (-68.2%)
|
-385.51M
est: 846.05M (-145.6%)
|
559.75M
559.75M – 559.75M
-33.8% YoY
|
781.29M
781.29M – 781.29M
+39.6% YoY
|
967.88M
967.88M – 967.88M
+23.9% YoY
|
| SGA |
430.98M
est: 1.03B (-58.0%)
|
537.32M
est: 1.22B (-56.1%)
|
660.16M
est: 1.18B (-44.3%)
|
775.21M
est: 935.65M (-17.1%)
|
962.71M
est: 956.20M (+0.7%)
|
1.17B
est: 1.24B (-5.7%)
|
1.14B
est: 1.34B (-14.7%)
|
1.04B
est: 1.34B (-22.0%)
|
1.23B
est: 1.74B (-29.4%)
|
1.14B
est: 1.38B (-17.4%)
|
1.13B
est: 1.41B (-19.8%)
|
1.17B
est: 1.36B (-13.7%)
|
1.16B
est: 1.49B (-22.4%)
|
1.30B
est: 1.76B (-26.2%)
|
1.62B
1.62B – 1.62B
-8.2% YoY
|
1.96B
1.96B – 1.96B
+21.0% YoY
|
2.25B
2.25B – 2.25B
+14.6% YoY
|
| EPS |
0.45
|
0.44
|
0.51
est: 0.46 (+10.1%)
|
0.51
est: 0.51 (+0.0%)
|
0.38
est: 0.04 (+795.8%)
|
0.34
est: 0.37 (-7.9%)
|
0.41
est: 0.42 (-1.4%)
|
0.38
est: 0.42 (-8.7%)
|
0.36
est: 0.49 (-25.9%)
|
0.13
est: 0.36 (-63.8%)
|
0.22
est: 0.34 (-35.4%)
|
-0.33
est: 0.19 (-273.7%)
|
0.07
est: 0.23 (-68.2%)
|
-0.12
est: 0.26 (-145.8%)
|
0.17
0.17 – 0.17
-33.8% YoY
|
0.24
0.24 – 0.24
+39.6% YoY
|
0.30
0.30 – 0.30
+23.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-28 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-27 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-26 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-22 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-21 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-20 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-19 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-18 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-15 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-14 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-13 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-12 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-11 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-08 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-07 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-06 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-05 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-04 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI China Small-Cap ETF ECNS | 0.19% | 124.9K | 0.59% |
| 2 | iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF ISFE.L | 0.03% | 20.9K | 0.74% |
| 3 | iShares MSCI Emerging Markets Small-Cap ETF EEMS | 0.03% | 98.6K | 0.72% |
| 4 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.03% | 186.0K | 0.65% |
| 5 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.02% | 74.6K | 0.74% |
| 6 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.02% | 23.3K | 0.42% |
| 7 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.02% | 98.1K | 0.55% |
| 8 | Schwab International Small-Cap Equity ETF SCHC | 0.01% | 741.8K | 0.06% |
| 9 | State Street SPDR S&P China ETF GXC | 0.01% | 56.7K | 0.59% |
| 10 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 1.50M | 0.06% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Liqun Xia | CEO, President & Executive Vice Chairman | 15M | male |
| Ka Yu Lam | Executive Co-Chairman & Vice President | 6M | female |
| Chiu Kwok Poon ACIS FCIS FCPA FCPA | Vice President, Company Secretary & Executive Director | 4M | male |
| Man Har Choy | Executive Director | 2M | female |
| Ka Yan Lam | Executive Director | 2M | female |
| Xu Gao | President of Tobacco Raw Materials Business Division | — | male |
| Cham Chen | Investor Relations Manager | — | male |
| De Xu Zhao | Vice President | — | male |
| Xiao Qin Yuan | President of Huabao Flavours & Fragrances Co., Ltd | — | female |
| Alan Davies | Chief Flavourist of Huabao Flavours & GM of Aromascape Development Centre - Germany | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 0336.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
